EMA Authorised: Artesunate Amivas (artesunate) — Amivas Ireland Ltd

View source ↗

Summary

The EMA authorises Artesunate Amivas (artesunate) for malaria, with Amivas Ireland Ltd as the marketing authorization holder, classified as an orphan medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artesunate Amivas (artesunate)

Snippet

Status: Authorised. Therapeutic area: Malaria. MAH: Amivas Ireland Ltd. Decision date: 17/08/2026. Orphan medicine